These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25941081)

  • 1. Signal transduction and chemotaxis in mast cells.
    Draber P; Halova I; Polakovicova I; Kawakami T
    Eur J Pharmacol; 2016 May; 778():11-23. PubMed ID: 25941081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
    Hong GU; Park BS; Park JW; Kim SY; Ro JY
    Cell Signal; 2013 Jun; 25(6):1514-25. PubMed ID: 23524335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells.
    Feuser K; Feilhauer K; Staib L; Bischoff SC; Lorentz A
    Mol Immunol; 2011 Jan; 48(4):546-52. PubMed ID: 21106245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.
    Galli SJ; Tsai M; Wershil BK
    Am J Pathol; 1993 Apr; 142(4):965-74. PubMed ID: 7682764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells.
    Kuehn HS; Rådinger M; Brown JM; Ali K; Vanhaesebroeck B; Beaven MA; Metcalfe DD; Gilfillan AM
    J Cell Sci; 2010 Aug; 123(Pt 15):2576-85. PubMed ID: 20587594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling.
    Bambouskova M; Polakovicova I; Halova I; Goel G; Draberova L; Bugajev V; Doan A; Utekal P; Gardet A; Xavier RJ; Draber P
    Mol Cell Biol; 2016 May; 36(9):1366-82. PubMed ID: 26929198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology.
    Toda M; Nakamura T; Ohbayashi M; Ikeda Y; Dawson M; Richardson RM; Alban A; Leed B; Miyazaki D; Ono SJ
    Novartis Found Symp; 2005; 271():131-40; discussion 140-51. PubMed ID: 16605132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation.
    Jensen BM; Metcalfe DD; Gilfillan AM
    Inflamm Allergy Drug Targets; 2007 Mar; 6(1):57-62. PubMed ID: 17352689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.
    Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C
    Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation of adapter molecules in proximal signaling cascades during allergic inflammation.
    Kambayashi T; Larosa DF; Silverman MA; Koretzky GA
    Immunol Rev; 2009 Nov; 232(1):99-114. PubMed ID: 19909359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Transcription Factor Ehf Is Involved in TGF-β-Induced Suppression of FcεRI and c-Kit Expression and FcεRI-Mediated Activation in Mast Cells.
    Yamazaki S; Nakano N; Honjo A; Hara M; Maeda K; Nishiyama C; Kitaura J; Ohtsuka Y; Okumura K; Ogawa H; Shimizu T
    J Immunol; 2015 Oct; 195(7):3427-35. PubMed ID: 26297757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. n-3 Polyunsaturated fatty acids inhibit Fc ε receptor I-mediated mast cell activation.
    Wang X; Ma DW; Kang JX; Kulka M
    J Nutr Biochem; 2015 Dec; 26(12):1580-8. PubMed ID: 26363927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1d expressed in mast cell surface enhances IgE production in B cells by up-regulating CD40L expression and mediator release in allergic asthma in mice.
    Hong GU; Kim NG; Kim TJ; Ro JY
    Cell Signal; 2014 May; 26(5):1105-17. PubMed ID: 24509414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the FcepsilonRI beta-chain in allergic diseases.
    Kraft S; Rana S; Jouvin MH; Kinet JP
    Int Arch Allergy Immunol; 2004 Sep; 135(1):62-72. PubMed ID: 15316148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, migration, and survival of mast cells.
    Okayama Y; Kawakami T
    Immunol Res; 2006; 34(2):97-115. PubMed ID: 16760571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL mediated signaling in human mast cells: the influence of IgE-dependent activation.
    Berent-Maoz B; Salemi S; Mankuta D; Simon HU; Levi-Schaffer F
    Allergy; 2008 Mar; 63(3):333-40. PubMed ID: 18269677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell factor expression, mast cells and inflammation in asthma.
    Da Silva CA; Reber L; Frossard N
    Fundam Clin Pharmacol; 2006 Feb; 20(1):21-39. PubMed ID: 16448392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.